We are live on ! Find out more
AMCA

Arthur M. Cohen & Associates Portfolio holdings

AUM $563M
1-Year Est. Return 20.97%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+20.97%
3 Year Est. Return
+97.14%
5 Year Est. Return
+130.41%
10 Year Est. Return
AUM
$224M
AUM Growth
+$34.8M
Cap. Flow
+$20.9M
Cap. Flow %
9.36%
Top 10 Hldgs %
53.13%
Holding
104
New
8
Increased
40
Reduced
26
Closed
10

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.2M
2
AAPL icon
Apple
AAPL
+$10.3M
3
AMZN icon
Amazon
AMZN
+$4.37M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.56M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.18M

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$7.11M
2
PG icon
Procter & Gamble
PG
+$1.37M
3
CL icon
Colgate-Palmolive
CL
+$1.33M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$723K
5
XOM icon
ExxonMobil
XOM
+$616K

Sector Composition

Rank Sector Weight
1 Healthcare 29.13%
2 Financials 20.45%
3 Consumer Staples 16.96%
4 Technology 7.65%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
101
Waste Management
WM
$91.9B
-3,380
Closed -$240K
XOM icon
102
ExxonMobil
XOM
$636B
-6,826
Closed -$616K
ZN
103
DELISTED
Zion Oil & Gas, Inc.
ZN
-18,804
Closed -$26K
ESRX
104
DELISTED
Express Scripts Holding Company
ESRX
-4,881
Closed -$336K

Similar funds

Arthur M. Cohen & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Arthur M. Cohen & Associates held 104 positions worth $224M, up 18% from $189M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Arthur M. Cohen & Associates deployed $20.9M of net new capital in Q1 2017, opening 8 new positions and adding to 40 existing holdings. Its largest new stake was Amgen: 67,669 shares worth $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $1.37M trimmed.

  • Arthur M. Cohen & Associates's largest Q1 2017 buy was Amgen: 67,669 shares worth $11.1M.
  • Arthur M. Cohen & Associates added most to Bristol-Myers Squibb in Q1 2017, an estimated $1.56M increase.
  • Arthur M. Cohen & Associates's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $1.37M.
  • Arthur M. Cohen & Associates fully exited Fortive in Q1 2017, selling an estimated $7.11M.
  • Arthur M. Cohen & Associates's ten largest holdings make up 53% of its $224M portfolio in Q1 2017.
  • Arthur M. Cohen & Associates opened 8 new positions and closed 10 in Q1 2017.
  • Arthur M. Cohen & Associates's portfolio value rose 18% quarter-over-quarter to $224M.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2017, filed 10 May 2017.